{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:19:32Z","timestamp":1791901172998,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.wneu.2024.10.012","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:35:02Z","timestamp":1731429302000},"page":"517-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Residual Pattern of the Hyperintense Area on T2-Weighted Magnetic Resonance Imaging After Initial Treatment Predicts the Pattern and Location of Recurrence in Patients with Newly Diagnosed Glioblastoma"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-9527","authenticated-orcid":false,"given":"Yoshiteru","family":"Shimoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3380-1192","authenticated-orcid":false,"given":"Masayuki","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-8655","authenticated-orcid":false,"given":"Shota","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6453-0076","authenticated-orcid":false,"given":"Ichiyo","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-3676","authenticated-orcid":false,"given":"Rei","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Mugikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Jingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2484-1360","authenticated-orcid":false,"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kumabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-6032","authenticated-orcid":false,"given":"Hidenori","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2024.10.012_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2013.51.8886","article-title":"Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery","volume":"32","author":"Marko","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib2","first-page":"3","article-title":"An extent of resection threshold for newly diagnosed glioblastomas","volume":"115","author":"Sanai","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"European organisation for research and treatment of cancer brain tumor and radiotherapy groups, national cancer institute of Canada clinical trials group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.10.012_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-010-0251-4","article-title":"Radiographic patterns of relapse in glioblastoma","volume":"101","author":"Chamberlain","year":"2011","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/neuonc\/not066","article-title":"The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence","volume":"15","author":"Shibahara","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11604-011-0031-x","article-title":"Recurrence patterns of glioblastoma treated with postoperative radiation therapy: relationship between extent of resection and progression-free interval","volume":"30","author":"Murakami","year":"2012","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.wneu.2024.10.012_bib7","first-page":"977","article-title":"The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection?","volume":"124","author":"Li","year":"2016","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","article-title":"Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma","volume":"6","author":"Molinaro","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib9","first-page":"1","article-title":"Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma","volume":"136","author":"Vivas-Buitrago","year":"2022","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/cancers15061772","article-title":"A\u00a0systematic review and meta-analysis of supramarginal resection versus gross total resection in glioblastoma: can we enhance progression-free survival time and preserve postoperative safety?","volume":"15","author":"Wach","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.wneu.2024.10.012_bib11","first-page":"40","article-title":"Upfront boost gamma Knife \u201cleading-edge\u201d radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy","volume":"125","author":"Duma","year":"2016","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1158\/1078-0432.CCR-20-1775","article-title":"Final results of the prospective biomarker trial PETra: [11C]-MET-accumulation in postoperative PET\/MRI predicts outcome after radiochemotherapy in glioblastoma","volume":"27","author":"Seidlitz","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.10.012_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/neuonc\/noac193","article-title":"Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group","volume":"25","author":"Karschnia","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib14","first-page":"86","article-title":"Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols","volume":"7","author":"Kumar","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.wneu.2024.10.012_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/bjc.1997.148","article-title":"Interstitial fluid pressure in intracranial tumours in patients and in rodents","volume":"75","author":"Boucher","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2024.10.012_bib16","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1158\/0008-5472.CAN-05-4328","article-title":"The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas","volume":"66","author":"Cao","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2024.10.012_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-021-03762-2","article-title":"Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema","volume":"153","author":"Dasgupta","year":"2021","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib18","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1016\/j.wneu.2018.09.139","article-title":"Can early postoperative O-(2-18Ffluoroethyl)-l-tyrosine positron emission tomography after resection of glioblastoma predict the location of later tumor recurrence?","volume":"121","author":"Buchmann","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2214\/ajr.162.3.8109520","article-title":"MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences","volume":"162","author":"Tien","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.wneu.2024.10.012_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004010050591","article-title":"Expression and distribution of vascular endothelial growth factor protein in human brain tumors","volume":"93","author":"Pietsch","year":"1997","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2024.10.012_bib21","first-page":"560","article-title":"Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis","volume":"81","author":"Strugar","year":"1994","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1245\/s10434-016-5635-z","article-title":"Dynamics of FLAIR volume changes in glioblastoma and prediction of survival","volume":"24","author":"Grossman","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib23","series-title":"Central Nervous System Tumous","year":"2021"},{"key":"10.1016\/j.wneu.2024.10.012_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2176\/nmc.oa2013-0212","article-title":"Treatment results of glioblastoma during the last 30 years in a single institute","volume":"53","author":"Kumabe","year":"2013","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2024.10.012_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:NEON.0000014539.90077.db","article-title":"Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma","volume":"66","author":"Giese","year":"2004","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib26","first-page":"428","article-title":"Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury","volume":"103","author":"Smith","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib27","first-page":"748","article-title":"Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know","volume":"139","author":"Young","year":"2023","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.10.012_bib28","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00701-009-0387-1","article-title":"Long-term survivors of glioblastoma: clinical features and molecular analysis","volume":"151","author":"Sonoda","year":"2009","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2024.10.012_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","article-title":"Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma","volume":"81","author":"Li","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2024.10.012_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12094-015-1381-0","article-title":"MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K BeadChip array and immunohitochemistry","volume":"18","author":"Trabelsi","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11060-014-1372-y","article-title":"Methylation-specific multiplex ligation-dependent probe amplification identifies promoter methylation events associated with survival in glioblastoma","volume":"117","author":"Rankeillor","year":"2014","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib33","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial","volume":"201","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2024.10.012_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2176\/nmc.oa.2021-0182","article-title":"Preoperative apparent diffusion coefficient of peritumoral lesion associate with recurrence in patients with glioblastoma","volume":"62","author":"Matsuda","year":"2022","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2024.10.012_bib35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/neuonc\/noz011","article-title":"Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification","volume":"21","author":"Wenger","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jocn.2021.01.037","article-title":"Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma","volume":"86","author":"Shibahara","year":"2021","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2024.10.012_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2176\/nmc.oa2013-0112","article-title":"A\u00a0multicenter phase I\/II study of the BCNU implant (Gliadel(\u00ae) Wafer) for Japanese patients with malignant gliomas","volume":"54","author":"Aoki","year":"2014","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2024.10.012_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jocn.2015.12.033","article-title":"The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema","volume":"31","author":"Hasegawa","year":"2016","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2024.10.012_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jocn.2016.06.014","article-title":"The survival significance of a measurable enhancing lesion after completing standard treatment for newly diagnosed glioblastoma","volume":"34","author":"Kim","year":"2016","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2024.10.012_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-019-03222-y","article-title":"Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma","volume":"144","author":"Lassman","year":"2019","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib41","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1002\/cam4.3370","article-title":"Ethnic delineation of primary glioblastoma genome","volume":"9","author":"Koo","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.wneu.2024.10.012_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-019-0749-8","article-title":"Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts","volume":"7","author":"Umehara","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.wneu.2024.10.012_bib43","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.23.01059","article-title":"Rano 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults","volume":"4","author":"Wen","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10147-010-0065-6","article-title":"O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma","volume":"15","author":"Sonoda","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.wneu.2024.10.012_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2010.09.020","article-title":"Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning","volume":"82","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2024.10.012_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bpa.12566","article-title":"Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis","volume":"28","author":"Korshunov","year":"2018","journal-title":"Brain Pathol"},{"key":"10.1016\/j.wneu.2024.10.012_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13000-016-0506-2","article-title":"Frequency of BRAF V600E mutations in 969 central nervous system neoplasms","volume":"27","author":"Behling","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.wneu.2024.10.012_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2176\/nmc.52.577","article-title":"Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases","volume":"52","author":"Konishi","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2024.10.012_bib49","article-title":"Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma","volume":"2","author":"Saito","year":"2020","journal-title":"Neurooncol Adv"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024017042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024017042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:30:48Z","timestamp":1749666648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875024017042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"alternative-id":["S1878875024017042"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2024.10.012","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual Pattern of the Hyperintense Area on T2-Weighted Magnetic Resonance Imaging After Initial Treatment Predicts the Pattern and Location of Recurrence in Patients with Newly Diagnosed Glioblastoma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2024.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}